Bristol-Myers buying heart drug maker Cardioxyl for $2.1B
Bristol-Myers Squibb Company is acquiring a private biotech company developing a medicine for one of the most common cause of hospitalizations in senior citizens, in a deal that could be worth up to USD 2.1 billion.
Nov 03, 2015, 22:48 PM IST